Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma J Liu, Y Yang, Z Liu, X Fu, X Cai, H Li, L Zhu, Y Shen, H Zhang, Y Sun, ... Journal for immunotherapy of cancer 10 (3), 2022 | 119 | 2022 |
Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism T Du, L Zhu, KM Levine, N Tasdemir, AV Lee, DAA Vignali, BV Houten, ... Scientific reports 8 (1), 1-11, 2018 | 102 | 2018 |
Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets D Varešlija, N Priedigkeit, A Fagan, S Purcell, N Cosgrove, PJ O’Halloran, ... JNCI: Journal of the National Cancer Institute 111 (4), 388-398, 2019 | 95 | 2019 |
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors L Zhu, JL Narloch, S Onkar, M Joy, G Broadwater, C Luedke, A Hall, ... Journal for immunotherapy of cancer 7, 1-10, 2019 | 92 | 2019 |
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy M Han, A Salamat, L Zhu, H Zhang, BZ Clark, DJ Dabbs, GJ Carter, ... Modern Pathology 32 (6), 807-816, 2019 | 72 | 2019 |
Low Estrogen Receptor (ER)–positive breast cancer and neoadjuvant systemic chemotherapy: is response similar to typical ER-positive or ER-negative disease? A Landmann, DJ Farrugia, L Zhu, EJ Diego, RR Johnson, A Soran, ... American journal of clinical pathology 150 (1), 34-42, 2018 | 69 | 2018 |
Comprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D cultures N Tasdemir, EA Bossart, Z Li, L Zhu, MJ Sikora, KM Levine, BM Jacobsen, ... Cancer research 78 (21), 6209-6222, 2018 | 67 | 2018 |
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors DJ Farrugia, A Landmann, L Zhu, EJ Diego, RR Johnson, M Bonaventura, ... Modern Pathology 30 (8), 1078-1085, 2017 | 40 | 2017 |
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation Z Li, O McGinn, Y Wu, A Bahreini, NM Priedigkeit, K Ding, S Onkar, ... Nature Communications 13 (1), 2011, 2022 | 39 | 2022 |
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... Cancer research 82 (7), 1321-1339, 2022 | 36 | 2022 |
Bayesian two-part spatial models for semicontinuous data with application to emergency department expenditures B Neelon, L Zhu, SEB Neelon Biostatistics 16 (3), 465-479, 2015 | 35 | 2015 |
MetaOmics: analysis pipeline and browser-based software suite for transcriptomic meta-analysis T Ma, Z Huo, A Kuo, L Zhu, Z Fang, X Zeng, CW Lin, S Liu, L Wang, P Liu, ... Bioinformatics 35 (9), 1597-1599, 2019 | 29 | 2019 |
MetaDCN: meta-analysis framework for differential co-expression network detection with an application in breast cancer L Zhu, Y Ding, CY Chen, L Wang, Z Huo, SH Kim, C Sotiriou, ... Bioinformatics 33 (8), 1121-1129, 2017 | 26 | 2017 |
Bayesian integrative model for multi-omics data with missingness Z Fang, T Ma, G Tang, L Zhu, Q Yan, T Wang, JC Celedón, W Chen, ... Bioinformatics 34 (22), 3801-3808, 2018 | 24 | 2018 |
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology M Blohmer, L Zhu, JM Atkinson, S Beriwal, JL Rodríguez-López, ... Breast Cancer Research 22, 1-14, 2020 | 20 | 2020 |
Postmastectomy radiation therapy based on pathologic nodal status in clinical node-positive stage II to III breast cancer treated with neoadjuvant chemotherapy Z Huang, L Zhu, XB Huang, Y Tang, QL Rong, M Shi, WH Wang, J Tie, ... International Journal of Radiation Oncology* Biology* Physics 108 (4), 1030-1039, 2020 | 17 | 2020 |
A novel mouse model for SNP in Steroid Receptor Co-activator-1 reveals role in bone density and breast cancer metastasis RJ Watters, K Verdelis, PC Lucas, S Jiang, Y Chen, F Lu, BM Martin, ... Endocrinology 162 (8), bqab094, 2021 | 7 | 2021 |
Impact of Ki-67 labeling index on prognostic significance of the chemotherapy response score in women with tubo-ovarian cancer treated with neoadjuvant chemotherapy M Heayn, LB Skvarca, L Zhu, RP Edwards, AB Olawaiye, F Modugno, ... International Journal of Gynecological Pathology 40 (3), 278-285, 2021 | 7 | 2021 |
Two-way horizontal and vertical omics integration for disease subtype discovery Z Huo, L Zhu, T Ma, H Liu, S Han, D Liao, J Zhao, G Tseng Statistics in Biosciences 12, 1-22, 2020 | 6 | 2020 |
Bayesian indicator variable selection to incorporate hierarchical overlapping group structure in multi-omics applications L Zhu, Z Huo, T Ma, S Oesterreich, GC Tseng The Annals of Applied Statistics 13 (4), 2611-2636, 2019 | 6 | 2019 |